HC | CD | UC | |
---|---|---|---|
Number of patients | 41 | 178 | 75 |
Age (years) | 33.6 ± 10.3 | 33.7 ± 12.2 | 41.2 ± 14.9 |
Gender | |||
Male | 18 | 115 | 43 |
Female | 23 | 63 | 32 |
Active/remission | 80/98 | 54/21 | |
Disease duration (months) | 35.3 ± 16.3 | 34.4 ± 18.1 | |
Current therapy | |||
5-Aminosalicylates | 63 | 49 | |
Salazosulfapyridine | 1 | 3 | |
Azathioprine | 47 | 6 | |
Glucocorticoids | 18 | 20 | |
Methotrexate | 6 | 4 | |
Biologics | 63 | 2 | |
Nutritional therapy | 45 | 6 | |
Age (CD)a | |||
A1 | 14 | ||
A2 | 122 | ||
A3 | 42 | ||
Disease location (CD)a | |||
L1 | 57 | ||
L2 | 49 | ||
L3 | 72 | ||
Disease behavior (CD)a | |||
B1 | 99 | ||
B2 | 65 | ||
B3 | 14 | ||
P | 33 | ||
Disease phenotype (UC)a | |||
E1 | 16 | ||
E2 | 23 | ||
E3 | 34 |